Literature DB >> 33752857

Nephrotoxin Stewardship.

Sandra L Kane-Gill1.   

Abstract

Drugs are the third leading cause of acute kidney injury (AKI) in critically ill patients. Nephrotoxin stewardship ensures a structured and consistent approach to safe medication use and prevention of patient harm. Comprehensive nephrotoxin stewardship requires coordinated patient care management strategies for safe medication use, ensuring kidney health, and avoiding unnecessary costs to improve the use of nephrotoxins, renally eliminated drugs, and kidney disease treatments. Implementing nephrotoxin stewardship reduces medication errors and adverse drug events, prevents or reduces severity of drug-associated AKI, prevents progression to or worsening of chronic kidney disease, and alleviates financial burden on the health care system.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Adverse drug event; Critically ill; Intensive care unit; Medication error; Nephrotoxin stewardship

Year:  2021        PMID: 33752857     DOI: 10.1016/j.ccc.2020.11.002

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  3 in total

1.  Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors.

Authors:  Diana J Schreier; Andrew D Rule; Kianoush B Kashani; Kristin C Mara; Sandra L Kane-Gill; John C Lieske; Alanna M Chamberlain; Erin F Barreto
Journal:  Am J Nephrol       Date:  2022-03-16       Impact factor: 4.605

2.  Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method.

Authors:  Matthew P Gray; Erin F Barreto; Diana J Schreier; John A Kellum; Kangho Suh; Kianoush B Kashani; Andrew D Rule; Sandra L Kane-Gill
Journal:  Drug Saf       Date:  2022-04-07       Impact factor: 5.228

3.  Pharmacy Practice Standards for Outpatient Nephrology Settings.

Authors:  Katie E Cardone; Rebecca Maxson; Katherine H Cho; Joseph M Davis; Wasim S El Nekidy; Sandra L Kane-Gill; Anusha McNamara; Lori Wazny; Lana Wong; Marisa Battistella
Journal:  Kidney Med       Date:  2022-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.